<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="341">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04388618</url>
  </required_header>
  <id_info>
    <org_study_id>H-01-R-059</org_study_id>
    <nct_id>NCT04388618</nct_id>
  </id_info>
  <brief_title>Investigating Anosmia and Ageusia in COVID-19 Adult Patients in Saudi Arabia</brief_title>
  <official_title>Investigating Anosmia and Ageusia in COVID-19 Adult Patients in Saudi Arabia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Princess Nourah Bint Abdulrahman University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Princess Nourah Bint Abdulrahman University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      COVID-19 has adversely affected the healthcare system across the world. The world was not&#xD;
      prepared for global outbreak of infectious diseases. The rapid spread of severe acute&#xD;
      respiratory syndrome coronavirus 2 (SARS-CoV-2) is enabling researchers worldwide to acquire&#xD;
      a large amount of clinical data regarding coronavirus disease (COVID-19).&#xD;
&#xD;
      The COVID-19 infection severely affects the respiratory system in the critical cases and&#xD;
      results in mortalities. The affected people experience a dry cough, fever, breathing&#xD;
      problems, diarrhea, muscle pain, and sore throat. Besides that, some of the evidence from&#xD;
      Italy, South Korea, China, and Spain suggest that the COVID-19 cases also lose their senses&#xD;
      of smell and taste resulting in alterations in those patients.&#xD;
&#xD;
      The objective of this proposed study is to determine whether COVID-19 cases have Olfactory&#xD;
      and gustatory dysfunctions as a hallmark indicator and can be used as diagnostic tools for&#xD;
      the isolation of suspected people.&#xD;
&#xD;
      Investigators are presenting a prospective proportional case-control study that is conducted&#xD;
      to investigate the COVID-19 cases with anosmia and /or Ageusia in a university hospital in&#xD;
      Riyadh, Saudi Arabia. The sample size of this case series would be 250 cases of suspected&#xD;
      COVID-19 patients. The cases included in the study are analyzed prospectively to determine if&#xD;
      the cases had a history of anosmia and /or Ageusia, and then tested for the alteration of&#xD;
      these senses through a panel of standardized odors/taste strips. That is looked at&#xD;
      statistically allowing us to confirm the proposed effectiveness of these tests as a&#xD;
      diagnostic tool.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Upon identification of the patient in the triage area the research assistant will start the&#xD;
      study by introducing the concept for the patient and then taking consent. The patient will go&#xD;
      through the regular flow of patients in the ED and after being asked to do the swabs the&#xD;
      research assistant will start the process of the study by testing the smell by the NHANES&#xD;
      cards then directly assess the taste by the NHANES strips and documents the results on the&#xD;
      cards and ask the patient to take a photo with his mobile and send it with his name to the&#xD;
      primary investigator via a mobile application and dedicated phone number. The research&#xD;
      assistant is the same person who is going to take the nasopharyngeal swab for the COVID-19&#xD;
      test. The cards are going to be collected in the negative pressure room of the patients and&#xD;
      then discarded in the same room. The investigators in the study are not aware of which&#xD;
      patient is answering what blinded investigator&#xD;
&#xD;
      Taste exam measures in NHANES The NHANES chemosensory tests used regional and whole mouth&#xD;
      taste intensities of bitter and salt tastants as measures of taste function, which were&#xD;
      similar to those implemented in the NIH Toolbox norming study. These NHANES taste measures&#xD;
      were selected based on their ability to capture genetic and environmentally mediated&#xD;
      variation in taste and for their potential relevance to diet and health.&#xD;
&#xD;
      Smell function in NHANES was assessed with an 8-item, odor identification test (Pocket Smell&#xD;
      Testsâ„¢, Sensonics, Inc., Haddon Heights, NJ). Of many available psychophysical measures of&#xD;
      olfactory function, odor identification tests are the most widely used in epidemiological and&#xD;
      clinical settings, as they are quick, relatively inexpensive, and easy to administer. The&#xD;
      odor identification test corresponds well with odor threshold tasks as well as other&#xD;
      suprathreshold olfactory measures (e.g., discrimination, odor intensity), and hence is&#xD;
      considered to be a rapid and accurate method for detecting olfactory dysfunction.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 15, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>correlation of anosmia and ageusia to covid19 positive patients</measure>
    <time_frame>from 1/06/2020 to 31/12/2020</time_frame>
    <description>to how extent alteration of smell and taste senses is related to covid19 status</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>objective assessment of severity of smell and taste senses alterations in covid19 patients</measure>
    <time_frame>from 1/06/2020 to 31/12/2020</time_frame>
    <description>to determine the range of sense affection ranging from total loss to mild form</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Anosmia</condition>
  <condition>Ageusia</condition>
  <condition>Covid19</condition>
  <condition>Corona Virus Infection</condition>
  <arm_group>
    <arm_group_label>covid19 positive patients</arm_group_label>
    <description>participants who present with signs and symptoms suspected for covid19 and swabbed/tested positive</description>
  </arm_group>
  <arm_group>
    <arm_group_label>covid19 negative patients</arm_group_label>
    <description>participants who present with signs and symptoms suspected for covid19 and swabbed/tested negative</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>NHANES smell and taste tests</intervention_name>
    <description>participants will be asked to smell 8 cards of different odors and submit your choices in a given card, and so for 3 different taste tips (salty, bitter and neutral). participants will be asked to submit his choices in a given card as well. Then participants photograph those cards and send it via WhatsApp to a given number to be collected</description>
    <arm_group_label>covid19 negative patients</arm_group_label>
    <arm_group_label>covid19 positive patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Upon identification of the patient in the triage area the research assistant will start the&#xD;
        study by introducing the concept for the patient and then taking consent. The patient will&#xD;
        go through the regular flow of patients in the ED and after being asked to do the swabs the&#xD;
        research assistant will start the process of the study by testing the smell by the NHANES&#xD;
        cards then directly assess the taste by the NHANES strips and documents the results on the&#xD;
        cards&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        1- Suspected cases of COVID -19 fulfilling the case definition of Saudi CDC 2- Adult&#xD;
        patients&#xD;
&#xD;
        -&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. The cases of children under the age of 12 years&#xD;
&#xD;
          2. Known patients with Kallmann's syndrome, CHARGE syndrome, Indifference to pain&#xD;
             syndrome, ciliopathy disorders.&#xD;
&#xD;
          3. Known patient with congenital anomalies, absent smell sense, and absent taste sense.&#xD;
&#xD;
          4. Pregnant and lactating ladies&#xD;
&#xD;
          5. Patients with trigeminal nerve disease&#xD;
&#xD;
          6. Blind and deaf patients&#xD;
&#xD;
          7. Malingering.&#xD;
&#xD;
          8. Adults aged more than 65 years old.&#xD;
&#xD;
          9. Allergy to quinine products&#xD;
&#xD;
             -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>OSAMA KENTAB, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Princess Nourah Bint Abdulrahman University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>AHMAD AALIBRAHIM, M.D</last_name>
    <role>Study Director</role>
    <affiliation>Princess Nourah Bint Abdulrahman University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>MARZOOQA ALENIZI, M.D</last_name>
    <role>Study Chair</role>
    <affiliation>Princess Nourah Bint Abdulrahman University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>OSAMA KENTAB, M.D</last_name>
    <phone>00966504237900</phone>
    <email>OYKENTAB@KAAUH.EDU.SA</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>KHALED SOLIMAN, M.D</last_name>
    <phone>00966564949749</phone>
    <email>KRSOLIMAN@KAAUH.EDU.SA</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Princess Nourah Bint Abdulrahman Univeristy</name>
      <address>
        <city>Riyadh</city>
        <state>Central</state>
        <zip>11552</zip>
        <country>Saudi Arabia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Osama Y Kentab, MD</last_name>
      <phone>+966504237900</phone>
      <email>oykentab@kaauh.edu.sa</email>
    </contact>
    <contact_backup>
      <last_name>Abdulaziz s Algarni, MD</last_name>
      <phone>+966501239461</phone>
      <email>absalgarni@kaauh.edu.sa</email>
    </contact_backup>
    <investigator>
      <last_name>Osama Y Kentab, M.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Khaled R Suliman, M.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>prince Mohammed bin Abdulaziz Hospital</name>
      <address>
        <city>Riyadh</city>
        <state>Central</state>
        <country>Saudi Arabia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>marzouga Alenazi, MD</last_name>
      <phone>0506295842</phone>
    </contact>
  </location>
  <location_countries>
    <country>Saudi Arabia</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>May 13, 2020</study_first_submitted>
  <study_first_submitted_qc>May 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 14, 2020</study_first_posted>
  <last_update_submitted>July 8, 2020</last_update_submitted>
  <last_update_submitted_qc>July 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Princess Nourah Bint Abdulrahman University</investigator_affiliation>
    <investigator_full_name>osama y kentab</investigator_full_name>
    <investigator_title>m.d, FAAP, FACEP , CLINICAL ASSOCIATE PROFESSOR OF EMERGENCY MEDICINE, SENIOR CONSULTANT PEDIATRIC EMERGENCY MEDICINE</investigator_title>
  </responsible_party>
  <keyword>anosmia</keyword>
  <keyword>ageusia</keyword>
  <keyword>covid19</keyword>
  <keyword>corona virus infection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Virus Diseases</mesh_term>
    <mesh_term>Coronavirus Infections</mesh_term>
    <mesh_term>Severe Acute Respiratory Syndrome</mesh_term>
    <mesh_term>Olfaction Disorders</mesh_term>
    <mesh_term>Ageusia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

